Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view-Reference-Cited by-同舟云学术

Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view

Published:1989-09 Issue:6 Volume:15 Page:349-357
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Schetz M.,Lauwers P. M.,Ferdinande P.

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00261492.pdf

Reference75 articles.

1. Aizawa Y, Ohmori T, Imai K, Nara Y, Matsuoka M, Hirasawa Y (1977) Depressant action of acetate upon the human cardiovascular system. Clin Nephrol 8:477

2. Amato N, Cozzolino F, Bergesio F, Salvadori M, Toreia MG, Carossino A, Sodi A (1988) In vitro interleukin-1 production by different dialysis membranes. Nephrol Dial Transplant 3:432

3. Baldamus CA, Ernst W, Frei U, Koch KM (1982) Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 31:324

4. Bartlett RH, Mault JR, Dechert RE, Palmer J, Schwartz RD, Port FK (1986) Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure? Surgery 2:400

5. Bauer W, Richards JW (1928) A vasodilator action of acetate J Physiol 66:371

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Filter lifetimes of different hemodiafiltration membrane materials in dogs: reevaluation of the optimal anticoagulant dosage;Renal Replacement Therapy;2021-02-08

2. The Effects of Nafamostat Mesilate on a Bleeding Risk as an Anticoagulant During Use as a Continuous Renal Replacement Therapy: Systematic Review;The Journal of Health Technology Assessment;2018-12

3. Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study;PLoS ONE;2014-10-10

4. The Role of Nafamostat Mesylate in Continuous Renal Replacement Therapy among Patients at High Risk of Bleeding;Renal Failure;2012-01-17

5. Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets;Antimicrobial Agents and Chemotherapy;2011-09-19